Use of EORTC Target Definition Guidelines for Dose-Intensified Salvage Radiation Therapy for Recurrent Prostate Cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10-Reference-Cited by-同舟云学术

Use of EORTC Target Definition Guidelines for Dose-Intensified Salvage Radiation Therapy for Recurrent Prostate Cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10

Published:2013-11 Issue:3 Volume:87 Page:534-541
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Sassowsky Manfred,Gut Philipp,Hölscher Tobias,Hildebrandt Guido,Müller Arndt-Christian,Najafi Yousef,Kohler Götz,Kranzbühler Helmut,Guckenberger Matthias,Zwahlen Daniel R.,Azinwi Ngwa C.,Plasswilm Ludwig,Takacs Istvan,Reuter Christiane,Sumila Marcin,Manser Peter,Ost Piet,Böhmer Dirk,Pilop Christiane,Aebersold Daniel M.,Ghadjar Pirus

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer;Han;J Urol,2003

2. Rising prostate-specific antigen after primary prostate cancer therapy;Ward;Nat Clin Pract Urol,2005

3. Prostate cancer-specific survival following salvage radiotherapy vs. observation in men with biochemical recurrence after radical prostatectomy;Trock;JAMA,2008

4. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy;Stephenson;J Clin Oncol,2007

5. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy;Wiltshire;Int J Radiat Oncol Biol Phys,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial;Clinical and Translational Radiation Oncology;2024-07

2. Radiotherapy trial quality assurance processes: a systematic review;The Lancet Oncology;2024-03

3. Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial;Advances in Radiation Oncology;2023-09

4. Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline;International Journal of Radiation Oncology*Biology*Physics;2023-09

5. Prostate Cancer;Target Volume Definition in Radiation Oncology;2023